medigraphic.com
SPANISH

Enfermedades Infecciosas y Microbiología

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 4

<< Back Next >>

Enf Infec Microbiol 2019; 39 (4)

Usefulness of tests from a private center to determine the local epidemiology of influenza

Pérez LY, González AÉE, Aguilar OG, Lara LE, MacíasAE
Full text How to cite this article

Language: Spanish
References: 8
Page: 118-122
PDF size: 230.43 Kb.


Key words:

acute respiratory diseases, influenza, respiratory syncytial virus.

ABSTRACT

Background. Immunological and nucleic acid tests are a new detection alternative that can facilitate an opportune diagnosis, shorten hospital stay times, lower costs and, finally, reduce the unnecessary use of antibiotics and infer epidemiological behavior of acute respiratory diseases.
Objectives. To describe the epidemiology of influenza and acute respiratory diseases in a private care center, with the use of rapid tests and molecular tests in addition to comparing the findings of the center with those reported by the national health authorities.
Material and methods. Descriptive analysis of the tests requested to the laboratory in the years 2016 to 2017, for the detection of influenza antigens and multiple polimerase chain reaction (PCR).
Results. 3 202 rapid influenza tests were performed, of which 1 620 were reactive (51%), 1 104 (68%) corresponded to influenza a and 517 (32%) to influenza b. Regarding molecular tests, the most common virus was the respiratory syncytial virus (25%) whose circulation predominated in November, December and January, followed by rhinovirus/enterovirus (22%).
Conclusions. The rapid tests and tests of molecular detections determined by a private center with regional coverage may have a value for the knowledge of the local epidemiology of acute respiratory diseases. These tests also generate information that may be useful for clinicians to make better diagnosis and treatment decisions.


REFERENCES

  1. Polansky, L., Outin-Blenman, S. y Moen, A., “Improved global capacity for influenza surveillance”, Emerg Infect Dis, 2016, 22 (6): 993-1001.

  2. Secretaría de Salud, Información epidemilógica. Disponible en: https://www.gob.mx/salud/acciones-y-programas/ informacion-epidemiologica. Consultada: 23 de enero de 2019.

  3. Ojeda, S., Munive, R., Moreno, L.C., Torres, A. y Melgar, V., “Epidemiología de las infecciones respiratorias en pacientes pediátricos empleando metodología de pcr múltiple”, Rev Latinoam Patol Clin Med Lab, 2016, 63: 190-195.

  4. Reina, J. y Dueñas, J., “Coinfecciones respiratorias entre los virus gripales y el virus respiratorio sincitial (2014- 2017)”, An Pediatr (Barcelona), 2018, 90 (2): 118-119.

  5. Castro-Cárdenas, L., Llaca-Díaz, J., Pérez-Chávez, F., Gómez-Espinel, I. y Flores-Aréchiga, A., “Estudio comparativo entre una prueba rápida y rt-pcr tiempo real en el diagnóstico de influenza ah1n1 2009”, Salud Pública Méx, 2011 53: 329-333.

  6. https://www.quidel.com/immunoassays/rapid-influenzatests/ sofia-influenza-fia. Consultada: 21 de octubre de 2018.

  7. https://www.biomerieux-diagnostics.com/filmarrayr-respiratory- panel. Consultada: 21 de octubre de 2018. Kilgore, P., Salim, A., Zervos, M. y Schmitt, H., “Pertussis:

  8. microbiology, disease, treatment, and prevention”, Clin Microbiol Rev, 2016, 29 :449-4869. Klein, N.P., Bartlett, J., Fireman, B. y Baxter, R., “Waning Tdap effectiveness in adolescents”, Pediatrics, 2016, 137: 1-9.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Enf Infec Microbiol. 2019;39